SPONSOR
Royal Marsden NHS Foundation Trust
Total Trials
10
Recruiting
10
Phases
Phase 1
Conditions studied: Oncogene-addicted Non Small Cell Lung CancerEarly-stage Operable Non Small Cell Lung CancerNon Small Cell Lung CancerMetastatic Non Small Cell Lung CancerLocally Advanced NSCLC - Non-Small Cell Lung CancerStage 2/3 Operable Non Small Cell Lung CancerOncologySoft Tissue Sarcoma of the ExtremitiesProstate CancerUrologic Cancer
Royal Marsden NHS Foundation Trust is a clinical research sponsor with 10 registered studies on ClinicalTrials.gov, of which 10 are actively recruiting participants. Research covers conditions including Oncogene-addicted Non Small Cell Lung Cancer, Early-stage Operable Non Small Cell Lung Cancer, Non Small Cell Lung Cancer, Metastatic Non Small Cell Lung Cancer.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Royal Marsden NHS Foundation Trust
How many clinical trials has Royal Marsden NHS Foundation Trust sponsored?
ClinicalMetric currently tracks 10 clinical trials sponsored by Royal Marsden NHS Foundation Trust, of which 10 are actively recruiting participants. These trials cover conditions including Oncogene-addicted Non Small Cell Lung Cancer, Early-stage Operable Non Small Cell Lung Cancer, Non Small Cell Lung Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Royal Marsden NHS Foundation Trust research focus on?
Royal Marsden NHS Foundation Trust clinical trials span Oncogene-addicted Non Small Cell Lung Cancer, Early-stage Operable Non Small Cell Lung Cancer, Non Small Cell Lung Cancer, Metastatic Non Small Cell Lung Cancer, Locally Advanced NSCLC - Non-Small Cell Lung Cancer, and additional conditions. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Royal Marsden NHS Foundation Trust clinical trial?
To participate in a Royal Marsden NHS Foundation Trust trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Royal Marsden NHS Foundation Trust trials with current recruitment status updated daily.
Clinical Trials by Royal Marsden NHS Foundation Trust
NCT07008742
Recruiting
Feasibility Study of Tissue and Blood Collection in Oncogene-addicted and Neoadjuvantly Treated Non Small Cell Lung Cancer
Oncogene-addicted Non Small Cell Lung Cancer
NCT03832062
Recruiting
Value of Analysing Under-utilised Leftover Tissue (VauLT)
Oncology
NCT05978024
Recruiting
Predicting Radiotherapy Response and Toxicities in Soft Tissue Sarcoma of the Extremities - Cohort B
Soft Tissue Sarcoma of the Extremities
NCT06357416
Recruiting
The Man Van Project
Prostate Cancer
NCT05644457
Recruiting
Exploratory Study of Early Biomarkers Allowing Dynamic Assessment of Response to Treatment in Cancers of the Head and Neck
Head and Neck Cancer
NCT04671940
Recruiting
Exploratory Study of Clonal Evolution in Cancer for Patients Undergoing Transoral Robotic Surgery for Radiation Exposed Residual/reCurrent Tumours of the Upper Aerodigestive Tract
Head and Neck Cancer
NCT05058183
Recruiting
Safe De-escalation of Chemotherapy for Stage 1 Breast Cancer
Breast Cancer
NCT06638541
Recruiting
Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions
Prostate Cancer
NCT05876676
Recruiting
RDC Biomarker Study
Cancer
NCT04360941 Phase 1
Recruiting
PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer
Triple Negative Breast Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology